A

Amgen

Makes biotech medicines for serious illnesses

Graduate Intern - PKDM-BA

Quantitative Biology & BiostatisticsPosted on Nov 12
Internship · Summer 2027South San Francisco, CA, USA$35.34 - $41.20 /hr

About the Job

Requirements

  • The applicant must be at least 18 years old.
  • The applicant must have graduated with a bachelor’s degree from an accredited college or university.
  • The applicant must be currently enrolled in the applicable MBA, Master’s, PharmD, or PhD program at an accredited college or university and must complete the first year of that program before the internship starts.
  • The applicant must be available to work a full-time schedule.
  • The applicant must remain enrolled in an accredited college or university following the internship or co-op program.
  • The student must be located in the United States for the duration of the internship program.
  • The candidate must be authorized to work in the United States for the duration of the program.

Responsibilities

  • Apply machine learning approaches to better understand small-molecule cellular biodistribution.
  • Develop and apply fit-to-purpose models to understand target tissue exposure and support translational research.
  • Present findings at group and departmental meetings.

Desired Qualifications

  • Major in Pharmaceutical Sciences, Pharmacology, Bioengineering, Computer Science, or a related field.
  • Have hands-on experience with cheminformatics and quantitative structure–activity relationship (QSAR) modeling, including integrating chemistry, informatics, and cell biology to understand how molecular properties and cell biology influence small-molecule uptake and distribution.
  • Be familiar with molecular descriptors, fingerprints, and QSAR analysis.
  • Have a conceptual understanding of pharmacokinetic and pharmacodynamic principles.
  • Have strong written and verbal communication skills.
  • Be able to work effectively in a multidisciplinary research environment.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs